KALA BIO, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALA BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $0.00.
- KALA BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $0.00.
- KALA BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $7.22M.
- KALA BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $118.21M.
- KALA BIO, INC. stock issued during period, value, new issues for fiscal 2025 was $9.13M.
- KALA BIO, INC. stock issued during period, value, new issues for fiscal 2023 was $1.97M.
- KALA BIO, INC. stock issued during period, value, new issues for fiscal 2020 was $125.42M.
- KALA BIO, INC. stock issued during period, value, new issues for fiscal 2018 was $66.13M, a 29.65% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $9.13M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $1.97M 10-K · filed 2024-03-29 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $125.42M 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2020-06-30 | $7.22M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $118.21M 10-Q · filed 2021-05-05 | |
| 2018-12-31 | $66.13M 10-K · filed 2020-02-12 | |
| 2017-12-31 | $94.00M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |